Amylx Pharmaceuticals Inc vs United Airlines Holdings Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while United Airlines Holdings Inc trades at $126.88 (market cap $41.00B). The key difference: United Airlines Holdings Inc is far larger — about 15.5× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | UAL | |
|---|---|---|
Market Cap | $2.64B | $41.00B |
Sector | Health | Industrials |
52-Week High | $24.19 | $136.11 |
52-Week Low | $7.82 | $85.21 |
Enterprise Value | $2.39B | $58.03B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →